Shattuck Labs Announces Positive Data from the Preclinical GLP Toxicology Study of SL-325 at the 20th Congress of European Crohn's and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025

Stock Information for Shattuck Labs Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Shattuck Labs Inc.

Shattuck Labs Announces Participation in Upcoming 24th Annual Needham Virtual Healthcare Conference
Shattuck Labs Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights
Shattuck Labs Announces Oral Presentation at Upcoming 20th Congress of European Crohn's and Colitis Organization (ECCO) in Inflammatory Bowel Diseases 2025
Shattuck Labs Announces Poster Presentation at Upcoming 2025 Crohn's and Colitis Congress
Shattuck Labs Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2025
Shattuck Labs Announces Participation in Upcoming December Conferences
Shattuck Labs Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.